Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 22% ± 5% | |
| glutamatergic neuron | 5 studies | 31% ± 12% | |
| astrocyte | 5 studies | 28% ± 15% | |
| epithelial cell | 4 studies | 27% ± 2% | |
| GABAergic neuron | 4 studies | 28% ± 7% | |
| oligodendrocyte precursor cell | 4 studies | 30% ± 13% | |
| ciliated cell | 3 studies | 21% ± 3% | |
| retina horizontal cell | 3 studies | 18% ± 1% | |
| retinal rod cell | 3 studies | 20% ± 4% | |
| interneuron | 3 studies | 46% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1484.86 | 245 / 245 | 100% | 11.13 | 502 / 502 |
| thymus | 100% | 1864.89 | 653 / 653 | 100% | 11.07 | 604 / 605 |
| ovary | 100% | 1272.63 | 180 / 180 | 100% | 10.75 | 429 / 430 |
| breast | 100% | 994.96 | 459 / 459 | 100% | 16.41 | 1114 / 1118 |
| brain | 100% | 1044.59 | 2636 / 2642 | 100% | 7.65 | 703 / 705 |
| esophagus | 100% | 1132.63 | 1445 / 1445 | 99% | 12.69 | 182 / 183 |
| lung | 100% | 837.36 | 576 / 578 | 98% | 11.03 | 1127 / 1155 |
| uterus | 100% | 1169.69 | 170 / 170 | 97% | 11.84 | 446 / 459 |
| kidney | 100% | 1303.00 | 89 / 89 | 97% | 7.99 | 874 / 901 |
| adrenal gland | 100% | 1216.83 | 258 / 258 | 97% | 7.57 | 223 / 230 |
| bladder | 100% | 1009.67 | 21 / 21 | 97% | 10.77 | 488 / 504 |
| stomach | 100% | 699.58 | 359 / 359 | 95% | 8.09 | 271 / 286 |
| skin | 100% | 1393.01 | 1809 / 1809 | 92% | 8.45 | 432 / 472 |
| pancreas | 99% | 488.46 | 324 / 328 | 92% | 6.74 | 163 / 178 |
| intestine | 100% | 995.48 | 966 / 966 | 90% | 8.16 | 475 / 527 |
| liver | 96% | 460.46 | 218 / 226 | 90% | 5.79 | 365 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.24 | 29 / 29 |
| spleen | 100% | 1427.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.69 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.57 | 1 / 1 |
| blood vessel | 100% | 831.71 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 708.38 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 897.34 | 850 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 78% | 4.51 | 62 / 80 |
| peripheral blood | 67% | 661.34 | 627 / 929 | 0% | 0 | 0 / 0 |
| muscle | 52% | 174.71 | 421 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF544 |
| Protein name | ZNF544 protein (Zinc finger protein 544) Zinc finger protein 544 |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000596652.5 ENST00000269829.5 M0QY11 ENST00000687789.1 M0QX86 M0R2F0 ENST00000599227.5 J3KQC8 M0QZM7 Q6NX49 ENST00000627781.2 ENST00000596825.5 ENST00000600044.5 ENST00000594384.5 ENST00000596929.5 ENST00000597240.5 M0QZY0 ENST00000599953.1 ENST00000595981.5 ENST00000596677.5 ENST00000600220.5 Q8IVS5 ENST00000652201.1 M0R0U7 |
